ENSC

Ensysce Biosciences, Inc.

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$0.39

Price (1 Year)

$1.77 $0.25

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %4.1 / %30
Non-compliant assets / Total market cap %0 / %30
Non-compliant revenue / Total income %0 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection (TAAP) platform, designed to release clinically effective drugs only when exposed to specific physiological conditions; and Multi-Pill Abuse Resistance (MPAR) platform, an over-dose protection opioid prodrug technology.

Website

Analysis (Turkish): ENSC Hissesi Caiz mi, Helal mi? Ensysce Biosciences, Inc. Katılım Analizi